Mcrae Capital Management Inc Amgen Inc Transaction History

Mcrae Capital Management Inc

$486 Million
Q3 2024

A detailed history of Mcrae Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Mcrae Capital Management Inc holds 1,995 shares of AMGN stock, worth $558,739. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,995

Previous 2,386 16.39%

Holding current value

$558,739

Previous $745,000 13.83%

% of portfolio

0.13%

Previous 0.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $120,967 - $131,915	-391 Reduced 16.39%	1,995 $642,000
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $43,019 - $51,929	-160 Reduced 6.28%	2,386 $678,000
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $7,671 - $8,653	-30 Reduced 1.16%	2,546 $733,000
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $53,569 - $66,507	245 Added 10.51%	2,576 $692,000
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $2,020 - $2,278	-9 Reduced 0.38%	2,331 $525,000
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $21,917 - $24,390	95 Added 4.23%	2,340 $569,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $2,102 - $2,332	9 Added 0.4%	2,245 $547,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $141,907 - $182,400	750 Added 50.47%	2,236 $539,000
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $41,341 - $48,461	248 Added 20.03%	1,486 $274,000
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $4,521 - $5,097	-25 Reduced 1.98%	1,238 $235,000
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 7.34%	1,263 $246,000
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $277,935 - $313,335	-1,500 Reduced 52.39%	1,363 $283,000
Q2 2018 Jul 16, 2018	BUY	$166.05 - $186.51 $253,226 - $284,427	1,525 Added 113.98%	2,863 $528,000
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $4,235 - $4,950	-25 Reduced 1.83%	1,338 $228,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $230,060 - $257,048	1,363	1,363 $237,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Amgen Inc Transaction History